Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Cardiovascular Diseases 3Metabolic Syndrome 2Breast Neoplasms 2Stomach Neoplasms 1Sarcoidosis 1Rectal Neoplasms 1Obesity 1Non-alcoholic Fatty Liver Disease 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Lung Diseases, Interstitial 1Liver Cirrhosis 1Hodgkin Disease 1Fatigue 1Colorectal Neoplasms 1Cardiotoxicity 1

Interventions

pembrolizumab 2perflutren 1Vinorelbine 1Thoracoscopy 1Surveys and Questionnaires 1Sulfur Hexafluoride 1Radiotherapy 1Prednisone 1Pemetrexed 1Paclitaxel 1Nivolumab 1Immune Checkpoint Inhibitors 1Hypnosis 1Health Records, Personal 1Gemcitabine 1Drug Therapy 1Dexamethasone 1Conscious Sedation 1Clinical Protocols 1Carboplatin 1Bronchoscopy 1Bronchoalveolar Lavage 1Blood Pressure 1Bevacizumab 1Behavior Therapy 1Adrenal Cortex Hormones 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lung Diseases, Interstitial × Blood Pressure × Clear all
NCT02246023 2016-04-14

Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy

University of Zurich

Phase 4 Completed
78 enrolled
Thoracic

Lung Neoplasms, Sarcoidosis, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡